신경혈관 디바이스 시장 규모, 점유율, 성장 분석 : 질환 병리별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Neurovascular Devices Market size was valued at USD 4.01 Billion in 2024 and is poised to grow from USD 4.36 Billion in 2025 to USD 8.37 Billion by 2033, growing at a CAGR of 8.5% during the forecast period (2026-2033).

The escalating incidence of neurological and cardiovascular disorders is significantly driving the global demand for neurovascular devices. An increasing aging population and heightened awareness of neurovascular conditions are anticipated to further enhance sales of these devices. The growing preference for minimally invasive procedures, technological advancements in medical devices, and a focus on early diagnosis are additional factors expected to propel the market's expansion. Furthermore, the widespread occurrence of acute ischemic strokes presents new opportunities for suppliers in this sector. However, challenges such as high device costs, stringent regulatory requirements, and limited accessibility in developing regions may hinder market growth. The associated risks of complications and device failures could also negatively impact the future demand for neurovascular devices.

Top-down and bottom-up approaches were used to estimate and validate the size of the Neurovascular Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Neurovascular Devices Market Segments Analysis

Global Neurovascular Devices Market is segmented by Disease Pathology, End User and region. Based on Disease Pathology, the market is segmented into Cerebral Aneurysms, Ischemic Strokes, Carotid Artery Stenosis, Arteriovenous Malformation & Fistulas and Other Disease Pathologies. Based on End User, the market is segmented into Hospitals And Surgical Centers, Ambulatory Care Centers and Research Laboratories and Academic Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Neurovascular Devices Market

The rising prevalence of neurovascular diseases, driven by unhealthy lifestyle choices and habits, has led to an increased number of individuals affected by conditions such as strokes and cerebral aneurysms. This alarming trend highlights a critical need for effective neurovascular devices, as healthcare systems strive to address the growing burden of these disorders. Consequently, the heightened incidence of neurovascular issues is creating a strong demand for advanced medical technologies and devices designed to manage and treat these conditions effectively. The push for innovative solutions in this sector reflects a broader commitment to enhancing patient outcomes and addressing the challenges posed by neurovascular diseases.

Restraints in the Neurovascular Devices Market

The Neurovascular Devices market faces a significant constraint due to the high costs associated with these advanced technologies. While such expenses may be manageable for healthcare institutions in developed nations, they pose a considerable challenge for facilities in developing countries where budgets are often tight. This financial barrier can restrict access to essential neurovascular treatments, hindering the ability of healthcare providers to adopt and implement these innovative devices in regions that would benefit from them the most. Consequently, this limitation could impact overall patient outcomes and the effectiveness of neurovascular care in less affluent areas.

Market Trends of the Neurovascular Devices Market

The Neurovascular Devices market is witnessing a significant trend towards the development of minimally invasive devices, driven by the increasing consumer preference for procedures that facilitate quicker recovery and reduced complications. This shift is prompting manufacturers to innovate and enhance their offerings, focusing on technologies that streamline surgical interventions without compromising efficacy. As healthcare providers prioritize patient safety and comfort, the demand for neurovascular devices capable of supporting minimally invasive procedures is expected to grow. Continuous advancements and innovations in this domain are likely to propel sales, underscoring the importance for manufacturers to align their product development strategies with these evolving market dynamics.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Patent Analysis
• Case Studies
• Customer And Buying Criteria Analysis
• Trade Analysis

Global Neurovascular Devices Market Size by Disease Pathology & CAGR (2026-2033)

• Market Overview
• Cerebral Aneurysms
  • Embolic Coils
  • Bare Detachable Coils
  • Coated Detachable Coils
  • Flow Diversion Devices
  • Intracranial Stents
  • Microcatheters
  • Guidewires
• Ischemic Strokes
  • Clot Retriever Devices
  • Suction & Aspiration Devices
  • Vascular Snares
  • Microcatheters
  • Microguidewires
  • Balloon Catheters
• Carotid Artery Stenosis
  • Carotid Artery Stents
  • Embolic Protection Devices
  • Balloon Catheters
• Arteriovenous Malformation & Fistulas
  • Liquid Embolic Agents
  • Occlusion Balloon Catheters
  • Microcatheters
• Other Disease Pathologies

Global Neurovascular Devices Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals And Surgical Centers
• Ambulatory Care Centers
• Research Laboratories and Academic Institutes

Global Neurovascular Devices Market Size & CAGR (2026-2033)

• North America (Disease Pathology, End User)
  • US
  • Canada
• Europe (Disease Pathology, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Disease Pathology, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Disease Pathology, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Disease Pathology, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Acandis GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asahi Intecc Co. Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Imperative Care Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integer Holdings Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Penumbra Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Perflow Medical Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rapid Medical (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WL Gore & Associates (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Penumbra, Inc. (United States) (duplicate)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• InspireMD, Inc. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations